Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Aug;22(8):1399-1401.
doi: 10.1002/ejhf.1791. Epub 2020 Mar 13.

Hypo- and hyperkalaemia in heart failure. Navigating between Scylla and Charybdis

Patrick Rossignol  1 , Faiez Zannad  1
Affiliations
Free article
Editorial

Hypo- and hyperkalaemia in heart failure. Navigating between Scylla and Charybdis

Patrick Rossignol et al. Eur J Heart Fail. 2020 Aug.
Free article
No abstract available

PubMed Disclaimer

Comment on

References

    1. Kovesdy CP, Matsushita K, Sang Y, Brunskill NJ, Carrero JJ, Chodick G, Hasegawa T, Heerspink HL, Hirayama A, Landman GWD, Levin A, Nitsch D, Wheeler DC, Coresh J, Hallan SI, Shalev V, Grams ME; CKD Prognosis Consortium. Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis. Eur Heart J 2018;39:1535-1542.
    1. Cooper LB, Benson L, Mentz RJ, Savarese G, DeVore AD, Carrero JJ, Dahlstrom U, Anker SD, Lainsak M, Hernandez AF, Pitt B, Lund LH. Association between potassium level and outcomes in heart failure with reduced ejection fraction: a cohort study from the Swedish Heart Failure Registry. Eur J Heart Fail 2020;22:1390-1398.
    1. Aldahl M, Jensen AS, Davidsen L, Eriksen MA, Moller Hansen S, Nielsen BJ, Krogager ML, Køber L, Torp-Pedersen C, Søgaard P. Associations of serum potassium levels with mortality in chronic heart failure patients. Eur Heart J 2017;38:2890-2896.
    1. Lund LH, Pitt B. Is hyperkalaemia in heart failure a risk factor or a risk marker? Implications for renin-angiotensin-aldosterone system inhibitor use. Eur J Heart Fail 2018;20:931-932.
    1. Nunez J, Bayes-Genis A, Zannad F, Rossignol P, Nunez E, Bodi V, Miñana G, Santas E, Chorro FJ, Mollar A, Carratalá A, Navarro J, Górriz JL, Lupón J, Husser O, Metra M, Sanchis J. Long-term potassium monitoring and dynamics in heart failure and risk of mortality. Circulation 2017;137:1320-1330.

LinkOut - more resources